Testing effectiveness (Phase 2)Ended earlyNCT02688907
What this trial is testing
Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation
Who this might be right for
Small Cell Lung Cancer
Samsung Medical Center 7